200 related articles for article (PubMed ID: 30409111)
1. Case report: dual primary AIDS-defining cancers in an HIV-infected patient receiving antiretroviral therapy: Burkitt's lymphoma and Kaposi's sarcoma.
Kim SE; Jung Y; Oh TH; Kim UJ; Kang SJ; Jang HC; Park KH; Lee KH; Jung SI
BMC Cancer; 2018 Nov; 18(1):1080. PubMed ID: 30409111
[TBL] [Abstract][Full Text] [Related]
2. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
[TBL] [Abstract][Full Text] [Related]
4. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
[TBL] [Abstract][Full Text] [Related]
5. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
[TBL] [Abstract][Full Text] [Related]
7. Multiple AIDS-related malignancies just in the era of potent antiretroviral therapy. A rare but intriguing finding.
Manfredi R; Calza L; Chiodo F
Infez Med; 2003 Sep; 11(3):153-6. PubMed ID: 14985648
[TBL] [Abstract][Full Text] [Related]
8. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
9. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
10. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
11. Steroid-related development of Kaposi's sarcoma in a homosexual man with Burkitt's lymphoma.
Real FX; Krown SE; Koziner B
Am J Med; 1986 Jan; 80(1):119-22. PubMed ID: 3942143
[TBL] [Abstract][Full Text] [Related]
12. Study of 172 Cases of AIDS Associated Cancers.
Phatak UA; Gosavi VS; Chitale PV
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062808
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
15. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
16. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.
Bower M; Fox P; Fife K; Gill J; Nelson M; Gazzard B
AIDS; 1999 Oct; 13(15):2105-11. PubMed ID: 10546864
[TBL] [Abstract][Full Text] [Related]
17. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
[TBL] [Abstract][Full Text] [Related]
18. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
20. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]